UNATI trial will test red wine versus abstaining as if alcohol were a medication
Louis describes UNATI, a large randomized trial of about 10,000 people testing a set daily wine dose against reducing alcohol, with cardiovascular disease as the primary question and cancer and all-cause mortality as secondary endpoints.
